Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment.
Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.
A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy.
Autoimmunity in multiple sclerosis need not be abnormal.
Cerebrospinal fluid analysis in infectious diseases of the nervous system: when to ask, what to ask, what to expect.
Antigen-specific tolerization approaches in multiple sclerosis.
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
A program to facilitate retention of employment among persons with multiple sclerosis.
Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort.
[Symptomatic therapy in multiple sclerosis].
Remyelination in multiple sclerosis: realizing a long-standing challenge.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, inhibits proliferation and differentiation of th17 cells.
Erratum to: Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Pages
« first
‹ previous
…
586
587
588
589
590
591
592
593
594
…
next ›
last »